BioSpace News Archive

Data presented in collaboration with Celldex show that Exicure’s technology leads to a more potent anti-tumor response when combined with Celldex’s CDX-301

Late-breaking oral presentation reports profound, durable synergistic activity for immunotherapy combined with SRA737+LDG, its Chk1 inhibitor plus low dose gemcitabine (LDG), in small cell lung cancer models

Facility to become the largest of four state-of-the-art sites involved in manufacturing of AveXis gene therapies for pipeline of rare genetic diseases including spinal muscular atrophy

Satsuma Pharmaceuticals, Inc. announced that John Kollins, the Company’s President and Chief Executive Officer, will provide a corporate overview at the Needham & Company 18th Annual Healthcare Conference taking place on April 9 – 10, 2019 in New York, NY.

Cerus Corporation announced the closing of a new debt facility with MidCap Financial which is expandable up to $90 million.

Ra Pharmaceuticals, Inc. announced that data from its Phase 2 clinical trial of zilucoplan for the treatment of generalized myasthenia gravis have been selected for an Emerging Science dual oral and poster presentation at the 2019 American Academy of Neurology Annual Meeting in Philadelphia, PA, from May 4 to 10, 2019.

Apyx Medical Corporation, formerly known as Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today announced it has voluntarily withdrawn its application for premarket notification 510(k) regulatory clearance of J-Plasma/Renuvion for use in dermal resurfacing procedures.

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today reported financial results for the fourth quarter and full year ended December 31, 2018 and provided an update on its business.

Tomorrow on World Autism Awareness Day, The Center for Discovery will host a groundbreaking conference, “A New Landscape for Autism: The Science of Safe and Healing Environments.

Community Healthcare Trust Incorporated (NYSE: CHCT) announced it has increased its credit facility to $325 million through a third amendment to its credit facility.